Recruiting PHASE1 Sleep Apnea, Obstructive

New treatment option for Sleep Apnea, Obstructive

Official title Use of Passive Myofunctional Appliances for Snoring and Mild Obstructive Sleep Apnea

ClinicalTrials.gov ID: NCT05497180

What this study is testing

What it's testing
It is unknown whether passive myofunctional appliances can be used for the treatment of obstructive sleep apnea and snoring, nor how to select the appropriate size per individual patient. Exploring the possibility of using passive myofunctional appliances as a treatment option for patients with mild obstructive sleep apnea and/or snoring should be considered, especially as the time to fabricate and deliver custom designed dental sleep appliances can be significant (sometimes over a month).
  • Phase 1: an early, usually small safety study

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older. Healthy volunteers may be eligible.

You may be able to join if

  • Patients diagnosed with mild obstructive sleep apnea or snoring without sleep apnea.
  • Patients 18 years or older
  • Patients able to provide consent to treatment and participation in the study

You likely can't join if

  • Patients previously diagnosed as non-responders to oral appliance therapy for their sleep apnea
  • Patients undergoing other active therapies for their sleep apnea
  • Patients with a history of airway/sleep breathing surgical interventions
  • Participants with a history of airway/sleep breathing surgical intervention are not eligible to be a part of this study do to risk of skewing test...
  • Patients with craniofacial, syndromic, or neuromuscular disorders
  • Patients with acute medical conditions requiring immediate attention
See the full eligibility criteria
Who can join
  • Patients diagnosed with mild obstructive sleep apnea or snoring without sleep apnea.
  • Patients 18 years or older
  • Patients able to provide consent to treatment and participation in the study
What rules you out
  • Patients previously diagnosed as non-responders to oral appliance therapy for their sleep apnea
  • Patients undergoing other active therapies for their sleep apnea
  • Patients with a history of airway/sleep breathing surgical interventions
  • Participants with a history of airway/sleep breathing surgical intervention are not eligible to be a part of this study do to risk of skewing test results
  • Patients with craniofacial, syndromic, or neuromuscular disorders
  • Patients with acute medical conditions requiring immediate attention
  • Participants with an acute medical problem will be immediately referred to an appropriate physician and will not be allowed to enroll in the study until their health conditions are stable.

The study team makes the final eligibility decision.

Where it's taking place

  • Edmonton, Alberta, Canada

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Edmonton, Alberta, Canada. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.